FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA). Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest drug approvals
- Tryptyr (acoltremon) - May 28, 2025
- Yutrepia (treprostinil) - May 23, 2025
- Starjemza (ustekinumab-hmny) - May 22, 2025
- Nuvaxovid (COVID-19 Vaccine, Adjuvanted) - May 16, 2025
- Brekiya (dihydroergotamine mesylate) - May 14, 2025
- Emrelis (telisotuzumab vedotin-tllv) - May 14, 2025
- Avmapki Fakzynja Co-Pack (avutometinib and defactinib, co-packaged) - May 08, 2025
- Atzumi (dihydroergotamine mesylate) - April 30, 2025
- Imaavy (nipocalimab-aahu) - April 29, 2025
- Zevaskyn (prademagene zamikeracel) - April 28, 2025
- (penpulimab-kcqx) - April 23, 2025
- Mezofy (aripiprazole) - April 15, 2025
- Jobevne (bevacizumab-nwgd) - April 09, 2025
- Vanrafia (atrasentan) - April 02, 2025
- Qfitlia (fitusiran) - March 28, 2025
- Vykat XR (diazoxide choline) - March 26, 2025
- Blujepa (gepotidacin) - March 25, 2025
- Bomyntra (denosumab-bnht) - March 25, 2025
- Conexxence (denosumab-bnht) - March 25, 2025
- Gozellix (gallium Ga 68 gozetotide) - March 20, 2025